RACHEL ARCHER: Open Payments
NPI 1215645403 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,352 in 26 payments from 10 companies in 2025. Trend: 2023 $29 · 2024 $147 · 2025 $2,352
Food & beverage: $2,352
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 2 | $1,770 |
| PFIZER INC. | 5 | $130 |
| CSL Behring | 4 | $122 |
| Aimmune Therapeutics, Inc. | 4 | $115 |
| Alexion Pharmaceuticals, Inc. | 3 | $69 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $49 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $36 |
| Ferring Pharmaceuticals Inc. | 1 | $24 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: Rapiblyk, VYNDAQEL, Kcentra, VOWST, ULTOMIRIS, XIFAXAN, JOURNAVX, REBYOTA.
Industry payments across TX — which companies pay providers there.
